◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Chiome Bioscience Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ3 2025Aug 12, 2025Q4 2024Dec 31, 2024Q3 2024Aug 13, 2024Q4 2023Dec 31, 2023Q4 2022Dec 31, 2022Q4 2021Dec 31, 2021
+Operating Income -581.1M -- -659.2M -- -- --
Operating Margin % 103.2% -- 99.6% -- -- --
+Ordinary Income -563.3M -- -662.1M -- -- --
Revenue Growth % -- -- -- -- -- --
Line ItemQ3 2025Aug 12, 2025Q4 2024Dec 31, 2024Q3 2024Aug 13, 2024Q4 2023Dec 31, 2023Q4 2022Dec 31, 2022Q4 2021Dec 31, 2021
Current Assets 2.3B -- 1.6B -- -- --
Total Assets 2.5B 1.8B 1.8B 2.1B 2.1B 3.5B
Current Liabilities 493.4M -- 539.0M -- -- --
Total Liabilities 548.6M 506.4M 593.7M 523.5M 473.0M 419.7M
Total Equity 1.9B 1.2B 1.2B 1.6B 1.7B 3.1B
Equity Ratio -- 0.70 -- 0.74 0.76 0.87
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...